Author

Seongryong Kim

Korea Advanced Institute of Science and TechnologyPrimary ORCID profile (0000-0001-7370-0102 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Seongryong KimiD1 paper · Korea Advanced Institute of Science and Technology

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Eui Ho KimiD· 1 shared Eun Hye JeongiD· 1 shared Ha‐Eun HongiD· 1 shared Hyukjin LeeiD· 1 shared J ParkiD· 1 shared Jeong Hun KwakiD· 1 shared Jinah YeoiD· 1 shared Junghwa LeeiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Eui Ho KimORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Coordinated Tuning of Ionizable Lipids and Formulation Redirects mRNA Vaccines Toward Lymphoid-Specific CD4+ T Cell Immunity

Yeji Lee, Yelim Choi, Seongryong Kim, Jinah Yeo, Junghwa Lee, Eun Hye Jeong, Jeong Hun Kwak, Min-Sung Kang, Ha‐Eun Hong, Ok‐Hee Kim, Yun-Ho Hwang, J Park, Eui Ho Kim, Say‐June Kim, You-Jin Kim, Hyukjin Lee

This study shows that modifying ionizable lipids and formulation parameters of mRNA vaccines can enhance CD4+ T cell immunity and improve vaccine efficacy.

bioRxiv · Apr 18, 2026 · PreprintBioengineering